TY  - GEN
AU  - Li,Maolan
AU  - Chen,Wei
AU  - Zhang,Hongchen
AU  - Zhang,Yong
AU  - Ke,Fayong
AU  - Wu,Xiangsong
AU  - Zhang,Yijian
AU  - Weng,Mingzhe
AU  - Liu,Yingbin
AU  - Gong,Wei
TI  - MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer
SN  - 1949-2553
PY  - 2018///0221
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Cisplatin
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Gallbladder Neoplasms
KW  - drug therapy
KW  - Gene Expression Profiling
KW  - methods
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Male
KW  - Mice, Nude
KW  - MicroRNAs
KW  - Neoplasm Invasiveness
KW  - Oligonucleotide Array Sequence Analysis
KW  - Proto-Oncogene Mas
KW  - Proto-Oncogene Proteins c-akt
KW  - metabolism
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - RNA Interference
KW  - Signal Transduction
KW  - Time Factors
KW  - Transfection
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
KW  - bcl-2-Associated X Protein
KW  - src-Family Kinases
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.13067
ER  -